These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26041762)

  • 1. Mutations in SLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination.
    Damseh N; Simonin A; Jalas C; Picoraro JA; Shaag A; Cho MT; Yaacov B; Neidich J; Al-Ashhab M; Juusola J; Bale S; Telegrafi A; Retterer K; Pappas JG; Moran E; Cappell J; Anyane Yeboa K; Abu-Libdeh B; Hediger MA; Chung WK; Elpeleg O; Edvardson S
    J Med Genet; 2015 Aug; 52(8):541-7. PubMed ID: 26041762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A homozygous mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly.
    Srour M; Hamdan FF; Gan-Or Z; Labuda D; Nassif C; Oskoui M; Gana-Weisz M; Orr-Urtreger A; Rouleau GA; Michaud JL
    Clin Genet; 2015 Jul; 88(1):e1-4. PubMed ID: 25930971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.
    Heimer G; Marek-Yagel D; Eyal E; Barel O; Oz Levi D; Hoffmann C; Ruzzo EK; Ganelin-Cohen E; Lancet D; Pras E; Rechavi G; Nissenkorn A; Anikster Y; Goldstein DB; Ben Zeev B
    Clin Genet; 2015 Oct; 88(4):327-35. PubMed ID: 26138499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASCT1 (Slc1a4) transporter is a physiologic regulator of brain d-serine and neurodevelopment.
    Kaplan E; Zubedat S; Radzishevsky I; Valenta AC; Rechnitz O; Sason H; Sajrawi C; Bodner O; Konno K; Esaki K; Derdikman D; Yoshikawa T; Watanabe M; Kennedy RT; Billard JM; Avital A; Wolosker H
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9628-9633. PubMed ID: 30185558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients.
    Edvardson S; Gerhard F; Jalas C; Lachmann J; Golan D; Saada A; Shaag A; Ungermann C; Elpeleg O
    J Med Genet; 2015 Nov; 52(11):749-53. PubMed ID: 26307567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel SLC1A4 homozygous mutation causing congenital microcephaly, epileptic encephalopathy and spastic tetraparesis: a video-EEG and tractography - case study.
    Pironti E; Salpietro V; Cucinotta F; Granata F; Mormina E; Efthymiou S; Scuderi C; Gagliano A; Houlden H; Di Rosa G
    J Neurogenet; 2018 Dec; 32(4):316-321. PubMed ID: 29989513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional identification of ASCT1 neutral amino acid transporter as the predominant system for the uptake of L-serine in rat neurons in primary culture.
    Yamamoto T; Nishizaki I; Nukada T; Kamegaya E; Furuya S; Hirabayashi Y; Ikeda K; Hata H; Kobayashi H; Sora I; Yamamoto H
    Neurosci Res; 2004 May; 49(1):101-11. PubMed ID: 15099708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination.
    Harel T; Quek DQY; Wong BH; Cazenave-Gassiot A; Wenk MR; Fan H; Berger I; Shmueli D; Shaag A; Silver DL; Elpeleg O; Edvardson S
    Neurogenetics; 2018 Dec; 19(4):227-235. PubMed ID: 30043326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant-negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome.
    Pujol-Giménez J; Mirzaa G; Blue EE; Albano G; Miller DE; Allworth A; Bennett JT; Byers PH; Chanprasert S; Chen J; Doherty D; Folta AB; Gillentine MA; Glass I; Hing A; Horike-Pyne M; Leppig KA; Parhin A; Ranchalis J; Raskind WH; Rosenthal EA; Schwarze U; Sheppeard S; Strohbehn S; Sybert VP; Timms A; Wener M; ; Bamshad MJ; Hisama FM; Jarvik GP; Dipple KM; Hediger MA; Stergachis AB
    Ann Clin Transl Neurol; 2023 Jun; 10(6):1046-1053. PubMed ID: 37194416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of a knock-in mouse model for spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM).
    Ratz-Mitchem ML; Leary G; Grindeland A; Silvius D; Guter J; Kavanaugh MP; Gunn TM
    Mamm Genome; 2023 Dec; 34(4):572-585. PubMed ID: 37642681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel SLC1A4 Mutation (p.Y191*) Causes Spastic Tetraplegia, Thin Corpus Callosum, and Progressive Microcephaly (SPATCCM) With Seizure Disorder.
    Abdelrahman HA; Al-Shamsi A; John A; Ali BR; Al-Gazali L
    Child Neurol Open; 2019; 6():2329048X19880647. PubMed ID: 31763347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare cause of microcephaly, thin corpus callosum and refractory epilepsy due to a novel SLC1A4 gene mutation.
    Sarigecili E; Bulut FD; Anlas O
    Clin Neurol Neurosurg; 2022 Jul; 218():107283. PubMed ID: 35605507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral amino acid transporter ASCT1 is preferentially expressed in L-Ser-synthetic/storing glial cells in the mouse brain with transient expression in developing capillaries.
    Sakai K; Shimizu H; Koike T; Furuya S; Watanabe M
    J Neurosci; 2003 Jan; 23(2):550-60. PubMed ID: 12533615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylglycine analogs are inhibitors of the neutral amino acid transporters ASCT1 and ASCT2 and enhance NMDA receptor-mediated LTP in rat visual cortex slices.
    Foster AC; Rangel-Diaz N; Staubli U; Yang JY; Penjwini M; Viswanath V; Li YX
    Neuropharmacology; 2017 Nov; 126():70-83. PubMed ID: 28807674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe neurodevelopmental disorder with intractable seizures due to a novel SLC1A4 homozygous variant.
    Sedláčková L; Laššuthová P; Štěrbová K; Vlčková M; Kudr M; Buksakowska I; Staněk D; Seeman P
    Eur J Med Genet; 2021 Sep; 64(9):104263. PubMed ID: 34174466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of a knock-in mouse model for Spastic Tetraplegia, Thin Corpus Callosum, and Progressive Microcephaly (SPATCCM).
    Ratz ML; Leary G; Grindeland A; Silvius D; Guter J; Kavanaugh MP; Gunn TM
    Res Sq; 2023 Apr; ():. PubMed ID: 37162879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel compound heterozygous variants (c.971delA/c.542C > T) in
    Mohamed FE; Ghattas MA; Almansoori TM; Tabouni M; Baydoun I; Kizhakkedath P; John A; Alblooshi H; Shaukat Q; Al-Jasmi F
    Front Pediatr; 2023; 11():1183574. PubMed ID: 37502193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural view onto disease-linked mutations in the human neutral amino acid exchanger ASCT1.
    Stehantsev P; Stetsenko A; Nemchinova M; Aduri NG; Marrink SJ; Gati C; Guskov A
    Comput Struct Biotechnol J; 2021; 19():5246-5254. PubMed ID: 34630942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants for functional differences between alanine-serine-cysteine transporter 1 and other glutamate transporter family members.
    Scopelliti AJ; Ryan RM; Vandenberg RJ
    J Biol Chem; 2013 Mar; 288(12):8250-8257. PubMed ID: 23393130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of rapid and high-affinity uptake of L-serine in neurons and astrocytes in primary culture.
    Yamamoto T; Nishizaki I; Furuya S; Hirabayashi Y; Takahashi K; Okuyama S; Yamamoto H
    FEBS Lett; 2003 Jul; 548(1-3):69-73. PubMed ID: 12885409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.